XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
Run-in safety study, to determine the safety of co-administration of irinotecan, raloxifene,
and Xiao Chai Hu Tang (XCHT), and to optimize the blood collection time points for
pharmacokinetic (PK) study for another randomized control trial.
Phase:
N/A
Details
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine